Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Clinical trial NCT00792142 · COMPLETED
Trial details
- NCT number
- NCT00792142
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-16
- Primary completion
- 2014-04-21
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.